This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v0.2.0: STU 1 Ballot 2) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
| Defining URL: | http://hl7.org/fhir/uv/pddi/ValueSet/valueset-nepafenac-exclude |
| Version: | 0.2.0 |
| Name: | Valueset_nepafenac_exclude |
| Status: | draft |
| Title: | Exclude Nepafenac Medications Value Set |
| Definition: | ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations. |
| Publisher: | PDDI CDS |
| Copyright: | Attribution CC BY |
| Source Resource: | XML / JSON / Turtle |
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://www.nlm.nih.gov/research/umls/rxnorm version 02-Jul-2018| Code | Display | |
| 603978 | nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac] | |
| 1365866 | nepafenac 3 MG/ML Ophthalmic Suspension [Ilevro] | |
| 603977 | nepafenac Ophthalmic Suspension [Nevanac] | |
| 1365864 | nepafenac Ophthalmic Suspension [Ilevro] | |
| 578044 | nepafenac 1 MG/ML Ophthalmic Suspension | |
| 1362132 | nepafenac 3 MG/ML Ophthalmic Suspension | |
| 578043 | nepafenac Ophthalmic Suspension | |
| 1158407 | nepafenac Ophthalmic Product | |
| 1365865 | Ilevro Ophthalmic Product | |
| 1182860 | Nevanac Ophthalmic Product |
This value set contains 10 concepts
Expansion based on RxNorm version ??
All codes from system http://www.nlm.nih.gov/research/umls/rxnorm
© HL7.org (HL7 Clinical Decision Support Workgroup). hl7.fhir.uv.pddi#0.2.0 based on FHIR v4.0.1. Generated 2020-08-10.
Links: Home
| QA Report | Search
| Version History
| 
| Propose a change